CVS HEALTH CORP. DL-,01/ US1266501006 /
11/11/2024 10:10:26 | Diferencia +0.40 | Volumen | Bid10:43:26 | Ask10:43:26 | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
52.41EUR | +0.77% | 0 Volumen de negocios: 0.00 |
51.98Volumen de oferta: 550 | 52.73Tamaño/ Volumen/ Formato de Ask: 550 | 65.21 mil millonesEUR | - | - |
GlobeNewswire
08/08
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
30/07
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Comme...
GlobeNewswire
11/04
Sharecare teams up with Anthem Blue Cross and Blue Shield on Jump Shot for Health initiative to supp...
GlobeNewswire
09/11/2023
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
27/09/2023
Payback Time! Community Pharmacists Cheer Class Action Lawsuit Against PBMs to Recoup DIR Fees
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página